rs1001179, CAT

N. diseases: 33
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2016 2016
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
1168 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2016 2016
Prostatic Diseases
CUI: C0033575
Disease: Prostatic Diseases
4 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2012 2012
Stage IV Prostate Cancer AJCC v7
CUI: C3146264
Disease: Stage IV Prostate Cancer AJCC v7
6 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2015 2015
Stage IV Prostate Cancer AJCC v8
CUI: C4553752
Disease: Stage IV Prostate Cancer AJCC v8
6 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2015 2015
Stage IV Prostate Carcinoma
CUI: C0278837
Disease: Stage IV Prostate Carcinoma
6 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2015 2015
Vitiligo
CUI: C0042900
Disease: Vitiligo
249 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2017 2017
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
CUI: C1847835
Disease: VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
92 0.641 0.680 11 34438684 upstream gene variant C/T snv 0.16 0.010 1.000 1 2017 2017